Moreover, Sun et al. revealed that high PGAM1 expression was associated with reduced patient survival, and PGAM1 silencing suppressed aggressive tumor phenotypes and mTOR-dependent glycolysis of NSCLC cell11. The gene discussed is PGAM1; the disease is neoplasm.